Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
A case report: Anesthesia management of an Ebstein Type B tricuspid valve malformation in an Adult Mical S. Duvall MD (1) , Pushpa Koyyalamudi MD (1), Lucas M. Duvall MD (2) 1. Louisiana State University Health Sciences Center, Department of Anesthesiology , Shreveport, LA 2. Louisiana State University Health Sciences Center, Department of Surgery, Division of Cardiothoracic Surgery, Shreveport, LA Intervention/Treatment Modality Introduction/Purpose Conclusions . Ebstein’s anomaly (EA) occurs in 1:210,000 live births and accounts for less than 1% of all congenital heart disease. It is a malformation of the Tricuspid valve (TV) associated with a wide spectrum of abnormalities often involving the right atrium and ventricle (1). We present a case of anesthetic management during tricuspid valve replacement, of a patient with an Epstein type B malformation. Patient Description A 58 year-old gentleman with history of hypertension, paroxysmal atrial fibrillation, ascites, jugular venous distension and severe Tricuspid regurgitation (TR), presented for Tricuspid valve replacement. The Electrocardiogram showed sinus bradycardia with first degree AV block. Following placement of a radial artery pressure-monitoring cannula, anesthesia was induced with midazolam and sufenanil. Central venous access was obtained and pulmonary artery catheter placement was successful without any evidence of arrhythmia. Transesophageal echocardiogram (TEE) revealed apical displacement of septal leaflet of TV with severe TR, severely dilated right atrium and right ventricle. Interventricular septum displayed diastolic bowing toward left ventricle with severely reduced left ventricular end diastolic volume and a normal EF. There was no evidence of Atrial septal defect . Initial CVP of 20 mmHg and normal Pulmonary artery pressures (PAP) were noted. No complications were observed in the pre-bypass period. 1. Ebstein’s Anamoly is a rare congenital heart disease involving the Tricuspid valve with Tricuspid regurgitation and variable degree of Right sided chamber enlargement and dysfunction 2. The goals of Anesthetic management of these patients should include interventions to improve right ventricular contractility and avoid increases in RV afterload. 3. Placement of PA catheter can be technically difficult and care should be taken to avoid arrhythmias. 4. CVP is typically elevated in these patients and peri-operative fluid management can be challenging. 5. TEE can accurately identify the lesion, its severity and associated cardiac defects. Intra-operative TEE is a valuable tool to help guide intravenous fluid therapy and pharmacologic interventions by assessing the right and left ventricular preload and changes in ventricular function. Surgical findings included a partial delamination defect of septal leaflet and some atrialization of Right Ventricle. Tricuspid valve was replaced with a bio-prosthetic valve and reduction atrialoplasty was done. Separation from cardiopulmonary bypass was accomplished with minimal use of inotropes (Epinephrine 0.04 mcg/kg/min) and vasodilators (Nitroglycerin 2-3 mcg/kg/min). CVP decreased to 7–10 mmHg with a mean PAP of 15-20 mmHg. Patient required AV pacing at 80 beats/min for junctional bradycardia. TEE revealed a normal functioning Tricuspid valve Bio-prosthesis with no residual regurgitation. The right ventricle remained dilated with improved function. The patient was extubated on the first postoperative day. He subsequently required permanent pacemaker for persistant complete heart block. Discussion The clinical manifestations of Ebstein’s anamoly in the adult depend on several factors, including the extent of TV leaflet distortion, degree of TR, right atrial pressure, and presence of a right to left atrial shunt. Echocardiography can accurately identify the lesion, its severity and associated cardiac defects (2). The anesthetic management of patient with EA should include interventions to improve right ventricular contractility and decrease afterload. TEE can give real time information as to the influence of pharmaceutical interventions on ventricular function and in patients with elevated CVP helps guide intravenous fluid therapy by assessing the right and left ventricular preload. References TEE 4-chamber view with severe enlargement of Right atrium and Right ventricle. Dilated Tricuspid valve Annulus and Apical Displacement of Septal leaflet is seen. 1. Ann Thoracic Surgery 2000; 69: 106-117 2. Current Treatment Options in Cardiovascular Medicine (2012) 14:594–607 Acknowledgments/Conflict of Interest The authors would like to thank the University as well as the Departments of Anesthesiology and Surgery for the time and funding necessary to see this study through to completion. The Authors have no current Conflicts of Interest. , TEE ME RV inflow-outflow view showing severe Tricuspid Regurgitation